(Q47103511)

8 January 2018

title

Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer (English)

1 reference

8 January 2018

1 reference

Michele R Wing

1

1 reference

8 January 2018

Julie W Reeser

2

1 reference

8 January 2018

Amy M Smith

3

1 reference

8 January 2018

Matthew Reeder

4

1 reference

8 January 2018

Dorrelyn Martin

5

1 reference

8 January 2018

Benjamin M Jewell

6

1 reference

8 January 2018

Jharna Datta

7

1 reference

8 January 2018

Jharna Miya

8

1 reference

8 January 2018

J Paul Monk

9

1 reference

8 January 2018

Amir Mortazavi

10

1 reference

8 January 2018

Gregory A Otterson

11

1 reference

8 January 2018

Richard M Goldberg

12

1 reference

8 January 2018

Jeffrey B VanDeusen

13

1 reference

8 January 2018

Sharon Cole

14

1 reference

8 January 2018

Kristin Dittmar

15

1 reference

8 January 2018

Sunny Jaiswal

16

1 reference

8 January 2018

Matthew Kinzie

17

1 reference

8 January 2018

Suraj Waikhom

18

1 reference

8 January 2018

Aharon G Freud

19

1 reference

8 January 2018

Xiao-Ping Zhou

20

1 reference

8 January 2018

Wei Chen

21

1 reference

8 January 2018

Darshna Bhatt

22

1 reference

8 January 2018

Sameek Roychowdhury

23

1 reference

8 January 2018

language of work or name

English

0 references

publication date

1 September 2017

1 reference

8 January 2018

published in

Oncotarget

1 reference

8 January 2018

volume

8

1 reference

8 January 2018

issue

44

1 reference

8 January 2018

page(s)

75822-75833

1 reference

8 January 2018

Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Performance comparison of benchtop high-throughput sequencing platforms

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Oncogenic MAP2K1 mutations in human epithelial tumors.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Personalized oncology through integrative high-throughput sequencing: a pilot study

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5652665

Tumor Genetic Screening Programs: A Call to Action

23 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29100271

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29100271

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.20616

1 reference

8 January 2018

PMCID

5652665

1 reference

8 January 2018

PubMed ID

29100271

1 reference

8 January 2018